Spyre Therapeutics, Inc. SYRE Professional Service Fees Payable
Professional Service Fees Payable at other companies
Other financials
Where this comes from
Reported directly by Spyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.
The official record: Spyre Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Spyre Therapeutics, Inc.'s professional service fees payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Spyre Therapeutics, Inc.'s professional service fees payable?
- Spyre Therapeutics, Inc. (SYRE) reported professional service fees payable of $1.42M in Q1 2026.
- How has Spyre Therapeutics, Inc.'s professional service fees payable changed year-over-year?
- Spyre Therapeutics, Inc.'s professional service fees payable increased by 129.3% year-over-year, from $621K to $1.42M.
- What is the long-term trend for Spyre Therapeutics, Inc.'s professional service fees payable?
- Over 3 years (2022 to 2025), Spyre Therapeutics, Inc.'s professional service fees payable has grown at a 14.1% compound annual growth rate (CAGR), from $946K to $1.4M.